title: Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?
authors.affiliation: a Department of Rheumatology , University Teaching Hospital, CHRU de Besançon , Besançon , France.|b EA4266 and EA4267 , Université de Bourgogne Franche-Comté , Besançon , France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.affiliation: a Department of Rheumatology , University Teaching Hospital, CHRU de Besançon , Besançon , France.|b EA4266 and EA4267 , Université de Bourgogne Franche-Comté , Besançon , France.
authors.forename: Frank
authors.initials: F
authors.lastname: Verhoeven
authors.affiliation: a Department of Rheumatology , University Teaching Hospital, CHRU de Besançon , Besançon , France.|b EA4266 and EA4267 , Université de Bourgogne Franche-Comté , Besançon , France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.affiliation: a Department of Rheumatology , University Teaching Hospital, CHRU de Besançon , Besançon , France.|b EA4266 and EA4267 , Université de Bourgogne Franche-Comté , Besançon , France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D018501:Antirheumatic Agents / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha
keywords: Anti TNF therapy; biodrugs; drug levels; immunogenicity; spondyloarthritis